藥物成份

共有 21663 個藥物成份

Quetiapine Fumarate contains not less than 98.0% and not more than 102.0%.

• 關聯藥證數量: 1

Quetiapine Fumarate contains not less than 98.5% and not more than 101.0% of (C21H25N3O2S)2 C4H4O4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Quetiapine Fumarate contains not less than 99.0 per cent and not more than 101.0 per cent of quetiapine fumarate(C46H54N6O8S2) (dried substance), and not less than 12.5 per cent and not more than 13.8 per cent of fumaric acid(C4H4O4) (dried substance).

• 關聯藥證數量: 1

Quetiapine Fumarate contains not less than 99.0 percent and not more than 101.0 percent of quetiapine fumarate (C46H54N6O8S2)(dried substance), and not less then 12.5 percent and not more than 13.8 percent of fumaric acid(C4H4O4)(dried substance).

• 關聯藥證數量: 1

Quetiapine Fumarate contains not less than 99.0% and not more than 101.0% of (C21H25N3O2S)2, C4H4O4 calculated on the dried substance.

• 關聯藥證數量: 1

Quetiapine Fumarate contains not less than 99.0% and not more than 101.0% of (C21H25N3O2S)2‧C4H4O4, calculated on anhydrous basis.

• 關聯藥證數量: 1

Quetiapine Fumarate contains not less than 99.0% and not more than 101.0% of C46H54N6O8S2 (dried substance).

• 關聯藥證數量: 1

Quetiapine Fumarate contains not less than 99.0% and not more than 101.0% of C46H54N6O8S2, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Quetiapine Fumarate contains not less than 99.0% and not more than 101.0%.

• 關聯藥證數量: 1

Quetiapine Hemifumarate contains not less than 98.0% and not more than 102.0% of (C21H25N3O2S)2．C4H4O4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Quetiapine Hemifumarate contains not less than 98.0% and not more than 102.0% of C42H50N6O4S2‧C4H4O4, calculated on dried substance.

• 關聯藥證數量: 1

Quetiapine Hemifumarate contains not less than 98.0% and not more than 102.0% of C42H50N6O4S2‧C4H4O4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Quetiapine fumarate (C46H54N6O8S2): 99.0% to 101.0% (dried substance) Fumaric Acid (C4H4O4): 12.5% to 13.8% (dried substance)

• 關聯藥證數量: 1

Quinupristin/dalfopristin：0.002-32 μg/mL

• 關聯藥證數量: 1

R Test\n\nPIPESa buffer 225 75 mmol/L\nMg2+ 10 3.3 mmol/L\nSodium cholate 0.6 0.2 mmol/L\n4-Aminoantipyrine ³0.45 0.15 mmol/L\nPhenol ³12.6 4.2 mmol/L\nFatty alcohol polyglycol 3 1 %\nEther\nCE ³25 ³8.3 μkat/L (³0.5 kU/L)\nCHOD ³7.5 ³2.5 μkat/L (³0.15 kU/L)\nPOD ³12.5 ³4.1 μkat/L (³0.25 kU/L)\nPH 6.8 6.8\na) PIPES=Piperazine-1,4bis(2-ethanesulfonic acid)

• 關聯藥證數量: 1

R 瓶 A 中的單一試劑(液狀) R Pyrogallol red 50 μmol/L Sodium molybdate 40 μmol/L pH 2.5 Test Pyrogallol red 44 μmol/L Test Sodium molybdate 35 μmol/L pH 2.5 此試劑中含非反應成分緩衝液，清潔劑及安定劑

• 關聯藥證數量: 1

R- I Ammonium Ferrous Sulfate Solution\n Sodium Citrate\n Ammonium Ferrous Sulfate

• 關聯藥證數量: 1

R- II Color Reagent\n 2-Nitroso-5- (N-Propy-N-Sulfopropyl amino ) -phenol ≧0.96mmol/L

• 關聯藥證數量: 1

R-1 : Sodium -HSDA\nR-2 : Cholesterol esterase \n Cholesterol oxidase \n Peroxidase\n 4-aminoantipyrine (4-AA)\n Surfactant\nHDL-C/LDL-C standard : Human serum

• 關聯藥證數量: 1

R-1 Stabilizing Solution\n Tris buffer\nR-2 Latex Solution\n Latex coated with anti-AFP polyclonal antibody 80μ/per test

• 關聯藥證數量: 1

R-1 agent A\nN-(2-hydroxy-3-sulfopropyl)-3.5-Dimethoxyaniline、Peroxidase (From horseradish)、\nR-2 agent B\nUricase、\n4-Aminoantipyrine

• 關聯藥證數量: 1

R-1: Dihydronicotinamide 0.26 mmol/L\n NaCl 255 mmol/L\nR-2: Pyruvate 8.2 mmol/L\n Tris-(hydroxypropyl methyl)-amino methane 408 mmol/L

• 關聯藥證數量: 1

R-1: Enzyme reagent 1: β-NADPH 113 μg/ml\n Buffer solution: α-ketoglutarate 10 mmol/L\nR-2: Enzyme reagent 2: glutamate dehydrogenase 150 IU/mL \n

• 關聯藥證數量: 1

R-1: Glycerol Kinase\n L-α-Glycerorin acid oxydase\n Ascolpin acid oxydase\n Peroxydase \n Adenosin-5\n N-Ethyl-N-Sulhomprobil-m-Torijin\n Magnesium chloride\n Good buffer\nR-2: Lipo protin li pase\n 4-amino anpyrin \n Magnesium chloride\n good buffer \n

• 關聯藥證數量: 1

R-1\nGLDH 2.0 x 104 U/L\nNADPH 0.34 mmol/L\nα-Ketoglutnamqte 6.3 mmol/L \nTroethanolamine 50 mmol/L\nR-2\nUrease 1.4 x 103 U/L \nTroethanolamine 100 mmol/L \n

• 關聯藥證數量: 1

R-1：1.L-Aspartic acid 2.Nicotinamide adeninedinucleotide phosphate (NADH) 3.Malate dehydrogenase (MDH)\nR-2：1.L-Aspartic acid 2.α-ketoglutaric acid

• 關聯藥證數量: 1

R-1：Thymol 13 mmol/L Veronal Buffer pH7.5

• 關聯藥證數量: 1

R-GLUTAMYL-P-NITROANILINE..........4.4MMOL/L GLYCYLGLYCINE.............................150MMOL/L

• 關聯藥證數量: 1

R-I Buffer (#843060): 80 mL x 4\nBuffer\nR-II Color presenting solution (#843070): 40 mL x 4\no-Creswol peptide coordination agent >= 0.12 mmol/L\n8-Hydroxyl quinoline >=17.22 mmol/L

• 關聯藥證數量: 1

R-I Buffer:\nDiethanolamine\nR-II Substrate solution: \nSodium p-nitrophenyl phosphate >51.19mmol/l

• 關聯藥證數量: 1

R-I Color Reagent A\n N-ethyl-(hydroxy-3-sulfopropy)-m-toluidine Na Toos≧1.83 mmol/L\nR-II Color Reagent B\n Uricase (from Yeast) ≧48 U/L\n 4-aminoantipyrine ≧1.18 mmol/L\n Peroxidase(from Horscradish)≧130U/L

• 關聯藥證數量: 1

R-I Enzyme antibody reagent: YAGI anti-HITO CK-M assistance component polychlonal antibody 28 U/L, adenosinediphosphate 2 mmol/L, glucose 10 mmol/L, hexokinase 2000 U/L, nicotinamide adenine dinucleotide phosphate 2.5 mmol/L, glucose-6-phosphate dehydrogenase 1000 U/L; R-II Substrate solution: phosphocreatine-disodium 153 mmol/L, adenosinediphosphate 2 mmol/L, glucose 60 mmol/L.

• 關聯藥證數量: 1

R-I Enzyme assistant enzyme reagent Hexokinase (comes from Yeast) ≧62U/dL Nicotinamide adenine dinucleotide phosphate (oxidative from) ≧1.31 mmol/L Glucose-6-phosphate dehydrogenase (comes from Brcillys ap.) ≧50U/dLR-II Coenzymke reagentSodium adenosinetriphosphate (ATP) ≧ 3.14 mmol/L

• 關聯藥證數量: 1

R-I Enzyme reagent: hexokinase 2000 U/L, nicotinamide adenine dinucleotide phosphate 2.55 mmol/L, glucose-6-phosphate dehydrogenase 1000 U/L, glucose 10 mmol/L; R-II Substrate solution: phosphocreatine-disodium 153 mmol/L, glucose 60 mmol/L.

• 關聯藥證數量: 1

R-I: Coenzyme reagent\nR-II: Substrate solution

• 關聯藥證數量: 1

R-I：Buffer\nR-II：Substrate solution

• 關聯藥證數量: 1

R-I：Coenzyme reagent\nR-II：Substrate solution

• 關聯藥證數量: 1

R-I：L-ascorbic acid；R-II：2-Nitroso 5-(N-propyl-N-sulfopropylamino) phenol 0.45 mmol/L

• 關聯藥證數量: 1

R-I：diluent\nR-II：molybdate ammonium ≧ 1.29 mmol/L

• 關聯藥證數量: 1

R0 Dibucaine 2.57mmol/L in vial A(liquid).R1 DTNB 1.3mmol/L in vial B (granulate). R2=SR S-Butyrylthiocholine iodide 75mmol/L in vial C (granulate)Active IngredientsComponents Concentrations (reconstituted) R0 R1 SR TestDibucaine 2.57 0.1 mmol/LPhosphate 250 50 mmol/L5,5’-dithiobis- 1.3 0.3 mmol/L 2-nitrobenzoate S-Butyrylthiocholine 75 6 mmol/L IodidePH 6.5 7.6 2.6 7.6

• 關聯藥證數量: 1

R1 AMP（buffer）pH10.2 413 mmol/L MgCl2 1.25 mmol/LR2 p-nitrophenylphosphate 32.5 mmol/L

• 關聯藥證數量: 1

R1 AcceleratorPolyethylene glycol (PEG) in phosphate buffer stabilized with 0.09% sodium azide in vial B (liquid).R2=SR Anti-α1-acid glycoprotein T antiserum (rabbit) specific for human α1-acid glycoprotein, in phosphate buffer stabilized with 0.09% sodium azide in vial C (liquid)

• 關聯藥證數量: 1

R1 Nitroblue in vial B (liquid).Nitroblue tetrazolium 1.2 mmol/LUricase (microbial) ≧12μkat/LNonreactiive buffer, stabilizer and surfactants.pH 7.5R2=SR Buffer in vial C (liquid).Carbonate 1.5 mol/LpH 10.4

• 關聯藥證數量: 1

R1 Reaction buffer Glycine buffer:170 mmol/L, pH8.0, polyethylene glycol 0.05%, bovine serum albumin, in vial B (liquid).R2=SR Latex particles coated with human IgG, glcine buffer: 170 mmol/L, pH7.3, in vial C (liquid).

• 關聯藥證數量: 1

R1 TRIS 224 mmol/L L-Alanine 1120 mmol/L LDH (microbial) ≧45 μkat/L(≧1.25kU/L) Albumin (bovine) 0.25 % Sodium azide 0.09 %R2 NADH ≧ 1.7 mmol/L 2-Oxoglutarate 94 mmol/L Sodium azide 0.09 %

• 關聯藥證數量: 1

R1 TRIS\n Polyethylene Glycol\n Sodium Azide\nR2 Anti-human complement C4 goat serum\n TRIS 100\n Sodium Azide\n

• 關聯藥證數量: 1

R1 Antibody reagent in vial A and B (liquid). Anti-T4 monoclonal antibody (mouse).R2=SR Tracer reagent in vial C (liquid). Fluorescein-labeled T4 derivative.

• 關聯藥證數量: 1

R1 Anti-albumin T antiserum (rabbit) specific for human albumin, in phosphate buffer stabilized with 0.09% sodium azide in vial B (liquid).R2 Reagent for antigen excess check (only used for urine application).Albumin in diluted serum (human) stabilized with 0.09% sodium azide in vial C (liquid).

• 關聯藥證數量: 1

R1 Antibody reagent in vial A (liquid). Anti-lidocaine polyclonal antibody (sheep) in buffer, pH 7.5, with stabilizer and preservative.RS=SR Tracer reagent in vial C (liquid). Fluorescein-labeled lidocaine derivative in buffer, pH 6.0, with stabilizer and preservative.

• 關聯藥證數量: 1

R1 Antibody reagent in vial A (liquid).Anti-NAPA monoclonal antibody (mouse) in buffer, pH7.5, with stabilizer and preservative.R2=SR Tracer reagent in vial C (liquid).Fluorescein-labeled NAPA derivative in buffer, pH6.5, with stabilizer, surfactant, and preservative.

• 關聯藥證數量: 1

R1 Antibody reagent in vial A and B (liquid). Anti-valproic acid monoclonal antibody (mouse). R2=SR Tracer reagent in vial C (liquid). Fluorescein-labeled valproic acid derivative.

• 關聯藥證數量: 1

R1 Guanidine hydrochloride in vial A (liquid).R2 Ascorbate in vial B (granulate).R3=SR FerroZine in vial C (liquid).

• 關聯藥證數量: 1

R1 Triethanolamine buffer: 151 mmol/l, pH 8.6; α-Ketoglutarate:16.6 mmol/l; ADP: ≧ 1.2 mmol/l; preservatives.R2 NADPH: ≧ 458 μmol/l; GLDH: ≧ 24.3 U/ml (EC 1.4.1.3; bovine liver; 25°C); Triethanolamine buffer: 151 mmol/l, pH 8.6; α-Ketoglutarate: 16.6 mmol/l; ADP: ≧ 1.2 mmol/l; preservatives.

• 關聯藥證數量: 1

R1 Accelerator Polyethylene glycol (PEG) 50g/L, in phosphate buffer stabilized with 0.09% sodium azide in vial A (liquid). R2=SR Anti-prealbumin T antiserum (rabbit) specific for human Prealbumin > 0.25g/L in phosphate buffer stabilized with 0.09% sodium azide in vial C (liquid).

• 關聯藥證數量: 1

R1 Antibody reagent in vial A (liquid). Anti-amikacin monoclonal antibody (mouse).R2 Diluent in vial B (liquid).R3=SR Tracer reagent in vial C (liquid). Fluorescein-labeled amikacin derivative.

• 關聯藥證數量: 1

R1 Imidazole buffer: 123 mmol/L, pH 6.5 (37 °C); EDTA: 2.46 mmol/L; Mg2+: 12.3 mmol/L; ADP: 2.46 mmol/L; AMP: 6.14 mmol/L; diadenosine pentaphosphate: 19 μmol/L; NADP+ (yeast): 2.46 mmol/L; N-acetylcysteine: 24.6 mmol/L; HK (yeast): ≥ 36.7 μkat/L; G6PDH (E.coli): ≥ 23.4 μkat/L; preservative; stabilizer; additive.\nR3 CAPSO* buffer: 20 mmol/L, pH 8.8 (37 °C); glucose: 120 mmol/L; EDTA: 2.46 mmol/L; creatine phosphate: 184 mmol/L; preservative; stabilizer; additive.\n

• 關聯藥證數量: 1

R1 TRIS buffer: 20 mmol/L, pH 8.0; NaCl: 200 mmol/L; polyethylene glycol: 3.6 %; preservative; stabilizers\n \nR3 Anti-human IgG antibody (goat): dependent on titer; TRIS buffer: 20 mmol/L, pH 8.0; NaCl: 150 mmol/L; preservative\n

• 關聯藥證數量: 1

R1 TRIS buffer: 20 mmol/L, pH 8.0; NaCl: 200 mmol/L; polyethylene glycol:\n 3.6 %; preservative; stabilizers\nR3 Anti-human IgA antibody (goat): dependent on titer; TRIS buffer:\n 20 mmol/L, pH 8.0; NaCl: 150 mmol/L; preservative\n

• 關聯藥證數量: 1

R1 Buffer (phosphate 68 mmol/L, pyruvate 0.73 mmol/L) in vial A and B (liquid).R2=SR Coenzyme (NADH 1.1 mmol/L) in vial C (liquid).

• 關聯藥證數量: 1

R1 Folate binding protein~Ru(bpy)2+3 (gray cap), 1 bottle, 9 mL: Ruthenium labeled folate binding protein 75 μg/L; human serum albumin (stabilizer); borate/phosphate/citrate buffer 70 mmol/L, pH 5.5; preservative.\nR2 Folate~biotin (black cap), 1 bottle, 8 mL: Biotinylated folate 17 μg/L; biotin 120 μg/L; human serum albumin (stabilizer); borate buffer 100 mmol/L, pH 9.0; preservative.

• 關聯藥證數量: 1

R1 Glycine buffer with bovine serum albumin stabilized with 0.09% sodium azide in vial A (liquid). R2=SR Latex particles coated with streptolysin O antigens in glycine buffer with bovine serum albumin, stabilized with 0.09% sodium azide in vial B (liquid).

• 關聯藥證數量: 1

R1 Glycine buffer: 170 mmol/L, pH 8.0; polyethylene glycol: 0.05 %; bovine\n serum albumin; stabilizer; preservative\nR3 Latex particles coated with human IgG; glycine buffer: 170 mmol/L, pH 7.3;\n stabilizer; preservative\n

• 關聯藥證數量: 1

R1 HEPES: 52.4 mmol/L; sodium chloride: 87 mmol/L; calcium chloride:\n 0.08 mmol/L; magnesium chloride: 12.6 mmol/L; α-glucosidase (microbial):\n ≥ 66.8 μkat/L; pH 7.0 (37 °C); preservatives; stabilizers\nR3 HEPES: 52.4 mmol/L; ethylidene-G7-PNP: 22 mmol/L; pH 7.0 (37 °C);\n preservatives; stabilizers\n

• 關聯藥證數量: 1

R1 Phosphate buffer: 12.7 mmol/L, NaCl: 0.13 mol/L; PEG: 40 g/L.R2 Anti-human α1-antitrypsin antibody (rabbit): > 2 g/L; NaCl: 0.12 mol/L.

• 關聯藥證數量: 1

R1 Anti-PCT-Ab~biotin (gray cap), 1 bottle, 9 mL: Biotinylated monoclonal anti-PCT antibody (mouse) 2.0 μg/mL; phosphate buffer 95 mmol/L, pH 7.5; preservative.

• 關聯藥證數量: 1

R1 Antibody reagent in vial A and B (liquid).

• 關聯藥證數量: 1

R1 Antibody reagent in vial A and B (liquid). Anti-phenytoin monoclonal antibody (mouse).R2=SR Tracer reagent in vial C (liquid). Fluorescein-labeled phenytoin derivative.

• 關聯藥證數量: 1

R1 Chlorophosphonazo Ⅲ in vial A and B (liquid).R2=SR EDTA in vial C (liquid).

• 關聯藥證數量: 1

R1 Citric acid:200 mmol/L; thiourea:115 mmol/L; detergentR2 Sodium ascorbate:150 mmol/L; FerroZine:6 mmol/L;preservative

• 關聯藥證數量: 1

R1 Conjugated amphetamine, methamphetamine, and MDMA derivatives;\n buffer; bovine serum albumin; 0.09 % sodium azide\nR2 Microparticles attached to amphetamine, methamphetamine, and\n MDMA antibodies (mouse monoclonal); buffer; bovine serum albumin;\n 0.09 % sodium azide\n

• 關聯藥證數量: 1

R1 Glycylglycine 110 mmol/L\n Tris buffer 130 mmol/L\nR2 r-glutamyl-p-nitroanililde 21 mmol/L\n Citric acid buffer 15 mmol/L

• 關聯藥證數量: 1

R1 Imidazole buffer: 123 mmol/L, pH 6.5 (37°C); EDTA: 2.46 mmol/L;\n Mg2+: 12.3 mmol/L; ADP: 2.46 mmol/L; AMP: 6.14 mmol/L;\n Diadenosine pentaphosphate: 19μmol/L; NADP (yeast): 2.46 mmol/L;\n N-acetylcysteine: 24.6 mmol/L; HK (yeast) ≧ 36.7 μkat/L; G6P-DH (E.coli):\n≧ 23.4 μkat/L.\nR2 CAPSO buffer: 20 mmol/L, pH 8.8 (37°C); glucose: 120 mmol/L;\n EDTA: 2.46 mmol/L; creatine phosphate: 184 mmol/L.\n

• 關聯藥證數量: 1

R1 Phosphate buffer: 200 mmol/L, GOD\n >= 183 ukat/L; POD>= 0.33 ukat/L; 4- aminophenazone:\n0.77 mmol/L; phenol: 11 mmol/L\n

• 關聯藥證數量: 1

R1 Sulfamic acid 70 mmol/L HCl 70 mmol/LR2 3.5-DCPD 5 mmol/L

• 關聯藥證數量: 1

R1 TRIS buffer: 50 mmol/L, pH 8.0; PEG: 4.2 %; EDTA: 2.0 mmol/L; preservative\nR2 Polyclonal anti-human albumin antibodies (sheep): dependent on titer;\n TRIS buffer: 100 mmol/L, pH 7.2; preservative\n Antigen Excess Reagent (for ACN 8253):\nR3 Albumin in diluted serum (human); NaCl: 150 mmol/L; phosphate\n buffer: 50 mmol/L, pH 7.0; preservative\n

• 關聯藥證數量: 1

R1 Tris buffer: ≧ 0.2 mol/l, pH 8.45; Ferrous ammonium sulfate: ≧ 8.4 μmol/l; Hydroxylamine hydrochloride: ≧0.1 mol/l; Nonionic surfactant: thiourea; Dilute sulfuric acidR2 FerroZine: 20.3 mmol/l; Preservative

• 關聯藥證數量: 1

R1 (Bottles 1,1a and 2)\n Citrate buffer: 150 mmol/L, pH 4.8；1-naphthyl phosphate:12.1 mmol/L；fast red TR salt: 1.2mmol/L；1,5-pentanediol:220 mmol/L；3.3mL/L；preservative.(Additionally for non-prostatic acid phosphatase determination: sodium tartrate:100 mmol/L)\n3 Acetic acid: 0.8 mol/L

• 關聯藥證數量: 1

R1 Alkaline buffer in vial B (liquid).

• 關聯藥證數量: 1

R1 Anti-IgM T antiserum (rabbit) specific for human\n IgM in phosphate buffer stabilized with 0.09% sodium azide in vial B (liquid).\n\nR2 Reagent for antigen excess check.\n IgM in diluted serum (human) stabilized with 0.09% sodium azide in vial C (liquid).\n

• 關聯藥證數量: 1

R1 Blank：Sodium hydroxide,EDTA-Na in vial A (liquid)\nR2=SR U/CSF Reagent：Benzethonium chloride in vial C (liquid)

• 關聯藥證數量: 1

R1 Buffer, preservatives

• 關聯藥證數量: 1

R1 Conjugate Reagent Gentamicin conjugate; piperazine-N, N-bis (ethanesulfonic acid) (PIPES) buffer pH 7.2; preservative. \nR2 Latex-Antibody Reagent Anti-gentamicin antibody (mouse monoclonal); latex microparticle; 3-(N-morpholino) propane sulfonic acid (MOPS) buffer pH 7.5; stabilizer; preservative.

• 關聯藥證數量: 1

R1 Conjugate Working Solution\n Conjugated methadone derivative in buffer.\nR2 Antibody/Microparticle Working Soltuion\n Microparticles attached to methadone antibody \n (mouse monoclonal).

• 關聯藥證數量: 1

R1 EA Solution enzyme acceptor (microbial): 0.22 g/l; anti-tobramycin antibody (mouse monoclonal): 25.5 mg/l; 3-(N-morpholino) propanesulfonic acid (MOPS) buffer; buffer salts; surfactant; carrier protein.R2 E D Solutionenzyme donor (microbial)-tobramycin: 23.4 μg/l; chlorophenol red-β-D-galactopyranoside: 2.4 g/l; goat anti-mouse antibodies: 3.3 g/l; 3-(N-morpholino) propanesulfonic acid (MOPS) buffer salts, surfactant

• 關聯藥證數量: 1

R1 H. influenzae type b latex:\nAnti-H. influenzae type b serum (rabbit) (sodium merthiolate 0.2 g/l+sodium azide 1 g/l).\nR2 Streptococcus pneumoniase omhi type latex:\nAnti-S. pneumoniae serum (rabbit) (sodium merthiolate 0.2 g/l+sodium azide 1g/l).\nR3 Neissria meningitides group A latex:\nAnti-N. meningitides A serum (rabbit) (sodium merthiolate 0.2 g/l+sodium azide 1 g/l). \nR4 Neisseria meningitides group B/ Escherichia coli K1 latex:\nAnti-N. meningitides B monoclonal antibody (mouse) (sodium merthiolate 0.2 g/l+sodium azide 1 g/l). \nR5 Neisseria meningitides group C latex:\nAnti-N. meningitides C serum (rabbit) (sodium merthiolate 0.2 g/l+sodium azide 1g/l). \nR6 Positive control: (lyophilized)\nAntigen extracts of H. influenzae b, S.pneumoniae, N.meningitides A, C, E.coli K1 (sodium merthiolate 0.1 g/l). \n

• 關聯藥證數量: 1

R1 HEPES buffer: 10.07 mmol/L; CHES: 96.95 mmol/L; dextran sulfate: 1.5g/L; magnesium nitrate hexahydrate: ≧11.7 mmol/L; HSDA: 0.96 mmol/L; ascorbate oxdase(Eupenicillium sp., recombinant)≧ 50 μkat/L (3.0 kU/L); peroxidase ≧16.7 μkat/L (1.0 kU/L).R2 HEPES buffer: 10.07 mmol/L,pH 7.0 ; PEG-cholesterol esterase (Pseudomonas spec.) ≧3.33 μkat/L(0.2 kU/L); PEG-cholesterol oxidase (Streptomyces sp., recombinant) ≧127 μkat/L (7.6 kU/L); peroxidase(horseradish)≧ 333 μkat/L (20 kU/L); 4-amino-antipyrine:2.46 mmol/LR2 HEPES buffer: 10.07 mmol/l; PEG-cholesterol oxidase > 127 μkat/l (7.6 kU/l); peroxidase > 333 μkat/l (20 kU/l); 4-amino-antipyrine:2.46 mmol/l\n

• 關聯藥證數量: 1

R1 HEPES buffer: 52.5 mmol/L, pH 7 (37˚C); sodium chloride: 87 mmol/L; magnesium chloride: 12.6 mmol/L; calcium chloride: 0.075 mmol/L; α-glucosidase (microorganisma)≧4 kU/L; monoclonal antibodies (mouse): 97 mg/L R2 HEPES buffer: 52.5 mmol/L, pH 7 (37˚C); 4,6-ethylidene-G7PNP; 22 mmol/L

• 關聯藥證數量: 1

R1 HEPES, α-Glucosidase, Mg2+, sodium chloride, and Ethylidene-G7-PNP\nR2=SR HEPES, and Ethylidene-G7-PNP

• 關聯藥證數量: 1

R1 Imidazole buffer: 123 mmol/L, pH 6.5 (37°C); EDTA: 2.46 mmol/L; Mg2+: 12.3 mmol/L; ADP: 2.46 mmol/L; AMP: 6.14 mmol/L; diadenosine pentaphosphate: 19 μmol/L; NADP (yeast): 2.46 mmol/L; N-acetylcysteine: 24.6 mmol/L; HK (yeast): ≧36.7 μkat/L (25°C); G6P-DH (E.coli): ≧23.4 μkat/L (25°C); preservative; stabilizer; additive.\nR2 CAPSO buffer: 20 mmol/L, pH 8.8 (37°C); glucose: 120 mmol/L; Mg2+: 11 mmol/L; EDTA: 2.46 mmol/L; creatine phosphate: 184 mmol/L; 4 monoclonal anti-CK-M antibodies (mouse), inhibiting capacity: >99.6% up to 66.8 μkat/L (4000 U/L) (37°C) CK-M subunit; preservative; stabilizer; additive.

• 關聯藥證數量: 1

R1 MES buffer: 5.0 mmol/L, pH 6.0; Mg2+: 24 mmol/L; ATP: ≥ 4.5 mmol/L;\n NADP: ≥ 7.0 mmol/L; preservative\nR3 HEPES buffer: 200 mmol/L, pH 8.0; Mg2+: 4 mmol/L; HK (yeast):\n ≥ 300 μkat/L; G-6-PDH (E. coli): ≥ 300 μkat/L; preservative\n

• 關聯藥證數量: 1

R1 NaCl 9 %\nR2 TRIS buffer: 220 mmol/L, pH 8.6; 2-oxoglutarate: 73 mmol/L; NADH: 2.5 mmol/L; ADP: 6.5 mmol/L; urease (jack bean): ≥ 300 μkat/L; GLDH (bovine liver): ≥ 80 μkat/L; preservative; nonreactive stabilizers

• 關聯藥證數量: 1

R1 PIPES buffera:50 mmol/l, pH 6.8;Mg2+:40 mmol/l;sodium cholate: 0.20mmol/l;ATP≧1.4 mmol/l;4-aminophenazone≧0.13 mmol/l;4-chlorophenol:4.7 mmol/l; potassium hexacyanoferrate(II):1μmol/l;fatty alchol polyglycol ether: 0.65%;lipoprotein lipase(pseudomonas spec.)≧5.0 U/ml; glycerokinase(Bacillus stearothermophilus)≧0.19 U/ml; Glycerol phosphate oxidase (E. coli)≧2.5 U/ml; peroxidase (horseradish)≧0.10 U/ml; preservative a)PIPES=piperazine-N,N'-bis(2-ethanesulfonic acid)

• 關聯藥證數量: 1

R1 Phosphate buffer: 12.7 mmol/l, pH7.2；NaCl: 0.13 mol/l；PEG: 70 g/l；preservative\nR2 Anti-human ceruloplasmin antibody (rabbit): dependent on titer；NaCl: 0.1 mol/l；preservative

• 關聯藥證數量: 1

R1 Phosphate buffer: 60 mmol/L, pH 7.5; NaCl: 100 mmol/L;polyethylene glycol (PEG): 30g/L; preservative, in vial A (liquid).\nR2 Latex particles coated with polyclonal anti-human Lp(a) antibodies (rabbit); glycine buffer: 25 mmol/L, pH 9.6; preservative, in vial B (liquid).\n

• 關聯藥證數量: 1

R1 Phosphate buffer: 68 mmol/L, pH 7.5; α-ketobutyrate:3.7 mmol/L; preservative

• 關聯藥證數量: 1

R1 Phosphate buffer、NaCl、polyethylene glycol.\nR2 Anti-human transterrin antibodies (rabbit)、NaCl.

• 關聯藥證數量: 1

R1 Pyrophosphate buffer: 92 mmol/L, pH 7.7; potassium hexacyanoferrate (III): 2.4 mmol/L\nR2 GOODs buffer: 10 mmol/L, pH 4.0; butyrylthiocholine: 46 mmol/L; stabilizers.

• 關聯藥證數量: 1

R1 R2 R3Potassium 80 mmol/LHydroxide 900 mmol/LPhosphate 135 12 mmol/LPicric acid 50 4.4 mmol/L

• 關聯藥證數量: 1

R1 Saturating reagent in vial B (liquid). R2=SR FerroZine in vial C (liquid). Active ingredientsComponents Concentrations R1 R2 Test TRIS 375 150 Mmol/LFerrous chloride 62 25 mmol/LSodium hydrogen carbonate 75 30 μmol/LFerroZine 20 2.5 mol/LHydroxylamine 160 20 mol/LSodium azide 0.02 0.01 %PH 8.4 2.5 8.4 Reagent R1 contains a nonreactive stabilizer.

• 關聯藥證數量: 1

R1 Sodium hydroxide: 0.20 mol/l\nR2 Picric acid: 25 mmol/l

• 關聯藥證數量: 1